Thyroid gland disorder treatments are indicated for thyroid disorders that occur in the thyroid gland of a human body. Thyroid disorder is defined as an abnormal release of thyroid hormones that play a key role in the regulation of metabolism. The thyroid disease occurs mainly due to a deficiency of iodine in the body. It has been observed that over 2 billion individuals have insufficient iodine intake, among which sub-Saharan Africa and South Asia are majorly affected. The introduction of various remedies to treat this deficiency is anticipated to boost the market growth in future.
The factors that drive the growth of the global thyroid gland disorder treatment market are growing patient population with iodine deficiency. In addition, owing to new drug-delivery technologies, companies are increasing their focus on innovative and improved drug formulations that further fuel the market growth. However, the availability of alternative treatment methods such as thyroid surgery and stringent government regulations hamper the market growth. In addition, increasing governmental awareness programs regarding the disease and its treatment is expected to provide lucrative growth opportunities to the market.
The report segments the global thyroid gland disorder treatment market based on disease type and drug type. Based on disease type, the market is divided into hyperthyroidism and hypothyroidism. In terms of drug type, the market is categorized into levothyroxine, liothyronine, propacil, imidazole, and others. Regionally, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key players of the global thyroid gland disorder treatment market include AbbVie, Pfizer Inc., Merck & Co., Inc., Allergan plc, Mylan N.V., GlaxoSmithKline plc, Novartis AG, RLC LABS, Inc., Sanofi S.A., and Abbott Laboratories.
- The study provides an in-depth analysis of the global thyroid gland disorder treatment market and the current trends & future estimations to elucidate imminent investment pockets from 2016 to 2023.
- The report presents a quantitative analysis of the market to enable stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of the market based on product type assists in understanding the trends in the industry.
- Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
Thyroid Gland Disorder Treatment Market Key Segments:
By Disease Type
By Drug Type
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South Africa
- Saudi Arabia
- Rest of LAMEA